Alzex Neuropharma Inc. (TRRI)
Develops drug treatments for Alzheimer's and brain diseases.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-99.4%
The outlook
TRRI is trading near its 52-week low with minimal price movement today. The stock sits well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst coverage appears unavailable for this micro-cap security.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$602
52-wk high
$0.07
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—